About Liraglutide
Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist compounded based on prescriptions from licensed providers to meet individual patient needs.
At MediVera Compounding Pharmacy™, we prepare liraglutide formulations in accordance with USP standards and using high-quality active pharmaceutical ingredients (API).
Medication Information + Usage
Liraglutide 6 mg/mL, 7.5 mL multi-dose vial
Follow the directions for subcutaneous injection administration here.
Store liraglutide in the refrigerator (36°F to 46°F / 2°C to 8°C). Do not freeze.
Related Products
Liraglutide FAQ
Liraglutide is a GLP-1 receptor agonist compounded for weight-management support, available by prescription from a licensed provider. It may be considered when a commercially available option is not preferred or appropriate for the patient’s needs.
As a GLP-1 receptor agonist, liraglutide is thought to help regulate appetite and blood-sugar patterns via effects on the brain and digestive tract. Any reference to this mechanism relates to the drug class, not to the compounded formulation specifically.
- Suitable for first-time GLP-1 users or those sensitive to GI side-effects.
- Allows gradual dose escalation to improve tolerability.
- Daily injections can feel more controllable than weekly options.
- Often more consistently available than compounded semaglutide or tirzepatide.
Store in the refrigerator (36 °F – 46 °F / 2 °C – 8 °C). Do not freeze.
Follow the directions for subcutaneous injection administration here.
Liraglutide is typically started at a low dose and increased gradually to improve tolerance. It is taken once daily. Your provider will personalize your dosing plan based on your needs and response.
Individual responses vary. Many patients begin noticing appetite changes within a few weeks once an effective dose is reached. Meaningful body-weight trends are typically evaluated over several months under provider supervision. No specific outcome is guaranteed.
Liraglutide may be inappropriate for individuals with pancreatitis, certain GI disorders, a personal or family history of medullary thyroid carcinoma (MTC), or thyroid tumors. Always share your full medical history with your provider.
No. Compounded medications are not reviewed or approved by the FDA. They are prepared by a licensed compounding pharmacy for an individual patient when a commercially available alternative is unavailable or unsuitable.
Patients need a prescription from a licensed provider. Your provider can submit a prescription to MediVera Compounding Pharmacy. Download the patient fax form request letter here to request a prescription from your provider.
• FAX: Submit a Fax Request Form to get started. • EMR: Submit prescriptions directly through your EMR system. • Phone: Call us at 877-531-1147 to speak with our team and place your prescription. • Provider Portal: Use our Provider Portal for quick and convenient online prescribing.
If you have any further questions, contact us at [email protected].